161 related articles for article (PubMed ID: 28316008)
21. Immunohistochemical and cytogenetic characterization of acantholytic squamous cell carcinoma of the breast.
Aulmann S; Schnabel PA; Helmchen B; Dienemann H; Drings P; Otto HF; Sinn HP
Virchows Arch; 2005 Mar; 446(3):305-9. PubMed ID: 15668805
[TBL] [Abstract][Full Text] [Related]
22. Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotype.
Patani N; Barbashina V; Lambros MB; Gauthier A; Mansour M; Mackay A; Reis-Filho JS
J Clin Pathol; 2011 Sep; 64(9):822-8. PubMed ID: 21676924
[TBL] [Abstract][Full Text] [Related]
23. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis.
Squire JA; Bayani J; Luk C; Unwin L; Tokunaga J; MacMillan C; Irish J; Brown D; Gullane P; Kamel-Reid S
Head Neck; 2002 Sep; 24(9):874-87. PubMed ID: 12211052
[TBL] [Abstract][Full Text] [Related]
24. Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-incidence area for both cancers in Henan, northern China.
Wang LD; Qin YR; Fan ZM; Kwong D; Guan XY; Tsao GS; Sham J; Li JL; Feng XS
Dis Esophagus; 2006; 19(6):459-67. PubMed ID: 17069589
[TBL] [Abstract][Full Text] [Related]
25. Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung.
Kang JU; Koo SH; Kwon KC; Park JW
Int J Oncol; 2010 Aug; 37(2):327-35. PubMed ID: 20596660
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a new cytogenetic subtype of ductal breast carcinomas.
Molist R; Remvikos Y; Dutrillaux B; Muleris M
Oncogene; 2004 Aug; 23(35):5986-93. PubMed ID: 15208688
[TBL] [Abstract][Full Text] [Related]
27. Squamous cell carcinoma of the breast in the United States: incidence, demographics, tumor characteristics, and survival.
Yadav S; Yadav D; Zakalik D
Breast Cancer Res Treat; 2017 Jul; 164(1):201-208. PubMed ID: 28432512
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas.
Geyer FC; Weigelt B; Natrajan R; Lambros MB; de Biase D; Vatcheva R; Savage K; Mackay A; Ashworth A; Reis-Filho JS
J Pathol; 2010 Apr; 220(5):562-73. PubMed ID: 20099298
[TBL] [Abstract][Full Text] [Related]
29. A prognostic DNA signature for T1T2 node-negative breast cancer patients.
Gravier E; Pierron G; Vincent-Salomon A; Gruel N; Raynal V; Savignoni A; De Rycke Y; Pierga JY; Lucchesi C; Reyal F; Fourquet A; Roman-Roman S; Radvanyi F; Sastre-Garau X; Asselain B; Delattre O
Genes Chromosomes Cancer; 2010 Dec; 49(12):1125-34. PubMed ID: 20842727
[TBL] [Abstract][Full Text] [Related]
30. Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology.
Geyer FC; de Biase D; Lambros MB; Ragazzi M; Lopez-Garcia MA; Natrajan R; Mackay A; Kurelac I; Gasparre G; Ashworth A; Eusebi V; Reis-Filho JS; Tallini G
Breast Cancer Res Treat; 2012 Feb; 132(1):15-28. PubMed ID: 21509527
[TBL] [Abstract][Full Text] [Related]
31. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.
Iakovlev VV; Arneson NC; Wong V; Wang C; Leung S; Iakovleva G; Warren K; Pintilie M; Done SJ
Clin Cancer Res; 2008 Jul; 14(14):4446-54. PubMed ID: 18628458
[TBL] [Abstract][Full Text] [Related]
32. Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis.
Rane SU; Mirza H; Grigoriadis A; Pinder SE
Breast Cancer Res Treat; 2015 Aug; 153(1):101-21. PubMed ID: 26255059
[TBL] [Abstract][Full Text] [Related]
33. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization.
Günther K; Merkelbach-Bruse S; Amo-Takyi BK; Handt S; Schröder W; Tietze L
J Pathol; 2001 Jan; 193(1):40-7. PubMed ID: 11169514
[TBL] [Abstract][Full Text] [Related]
34. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
[TBL] [Abstract][Full Text] [Related]
35. Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York.
Varma G; Varma R; Huang H; Pryshchepava A; Groth J; Fleming D; Nowak NJ; McQuaid D; Conroy J; Mahoney M; Moysich K; Falkner KL; Geradts J
Br J Cancer; 2005 Sep; 93(6):699-708. PubMed ID: 16222315
[TBL] [Abstract][Full Text] [Related]
36. Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q.
Riener MO; Nikolopoulos E; Herr A; Wild PJ; Hausmann M; Wiech T; Orlowska-Volk M; Lassmann S; Walch A; Werner M
Hum Pathol; 2008 Nov; 39(11):1621-9. PubMed ID: 18656243
[TBL] [Abstract][Full Text] [Related]
37. Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma.
Geyer FC; Kushner YB; Lambros MB; Natrajan R; Mackay A; Tamber N; Fenwick K; Purnell D; Ashworth A; Walker RA; Reis-Filho JS
Histopathology; 2009 Dec; 55(6):732-43. PubMed ID: 19922592
[TBL] [Abstract][Full Text] [Related]
38. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P
Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471
[TBL] [Abstract][Full Text] [Related]
39. An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers.
Natrajan R; Weigelt B; Mackay A; Geyer FC; Grigoriadis A; Tan DS; Jones C; Lord CJ; Vatcheva R; Rodriguez-Pinilla SM; Palacios J; Ashworth A; Reis-Filho JS
Breast Cancer Res Treat; 2010 Jun; 121(3):575-89. PubMed ID: 19688261
[TBL] [Abstract][Full Text] [Related]
40. Chromosomal rearrangements in myoepithelial carcinoma of the breast that presented as metachronic double cancer with invasive ductal carcinoma in the ipsilateral breast.
Kawashima H; Ariizumi T; Saijo Y; Moriyama M; Umezu H; Ikeda Y; Ogose A; Endo N
Cancer Genet; 2016 Nov; 209(11):501-505. PubMed ID: 27886676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
